Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era.

Sharpley FA, Neffa P, Panitsas F, Kothari J, Subesinghe M, Cutter D, Shcolnik Szor R, Martinez GA, Rocha V, Ramasamy K.

PLoS One. 2019 Jul 23;14(7):e0219857. doi: 10.1371/journal.pone.0219857. eCollection 2019.

2.

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Ntentas G, Dedeckova K, Andrlik M, Aznar MC, George B, Kubeš J, Darby SC, Cutter DJ.

Pract Radiat Oncol. 2019 May;9(3):179-187. doi: 10.1016/j.prro.2019.01.006. Epub 2019 Jan 29.

3.

Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological Studies.

Duane FK, McGale P, Brønnum D, Cutter DJ, Darby SC, Ewertz M, Hackett S, Hall P, Lorenzen EL, Rahimi K, Wang Z, Warren S, Taylor CW.

Pract Radiat Oncol. 2019 May;9(3):158-171. doi: 10.1016/j.prro.2019.01.004. Epub 2019 Jan 26.

4.

Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.

Taylor C, McGale P, Brønnum D, Correa C, Cutter D, Duane FK, Gigante B, Jensen MB, Lorenzen E, Rahimi K, Wang Z, Darby SC, Hall P, Ewertz M.

J Clin Oncol. 2018 Aug 1;36(22):2288-2296. doi: 10.1200/JCO.2017.77.6351. Epub 2018 May 23.

5.

Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.

Frobisher C, Glaser A, Levitt GA, Cutter DJ, Winter DL, Lancashire ER, Oeffinger KC, Guha J, Kelly J, Reulen RC, Hawkins MM.

Br J Cancer. 2017 Nov 21;117(11):1723-1731. doi: 10.1038/bjc.2017.347. Epub 2017 Oct 24.

6.

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.

Tseng YD, Cutter DJ, Plastaras JP, Parikh RR, Cahlon O, Chuong MD, Dedeckova K, Khan MK, Lin SY, McGee LA, Shen EY, Terezakis SA, Badiyan SN, Kirova YM, Hoppe RT, Mendenhall NP, Pankuch M, Flampouri S, Ricardi U, Hoppe BS.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):825-842. doi: 10.1016/j.ijrobp.2017.05.004. Epub 2017 Sep 21. Review. No abstract available.

7.

A cardiac contouring atlas for radiotherapy.

Duane F, Aznar MC, Bartlett F, Cutter DJ, Darby SC, Jagsi R, Lorenzen EL, McArdle O, McGale P, Myerson S, Rahimi K, Vivekanandan S, Warren S, Taylor CW.

Radiother Oncol. 2017 Mar;122(3):416-422. doi: 10.1016/j.radonc.2017.01.008. Epub 2017 Feb 21.

8.

Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.

Rugbjerg K, Maraldo M, Aznar MC, Cutter DJ, Darby SC, Specht L, Olsen JH.

Int J Cancer. 2017 May 15;140(10):2232-2245. doi: 10.1002/ijc.30655. Epub 2017 Mar 14.

9.

Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

van Nimwegen FA, Ntentas G, Darby SC, Schaapveld M, Hauptmann M, Lugtenburg PJ, Janus CPM, Daniels L, van Leeuwen FE, Cutter DJ, Aleman BMP.

Blood. 2017 Apr 20;129(16):2257-2265. doi: 10.1182/blood-2016-09-740332. Epub 2017 Jan 31.

10.

Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).

Bright CJ, Hawkins MM, Guha J, Henson KE, Winter DL, Kelly JS, Feltbower RG, Hall M, Cutter DJ, Edgar AB, Frobisher C, Reulen RC.

Circulation. 2017 Mar 28;135(13):1194-1210. doi: 10.1161/CIRCULATIONAHA.116.025778. Epub 2017 Jan 25.

11.

Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.

Fidler MM, Reulen RC, Henson K, Kelly J, Cutter D, Levitt GA, Frobisher C, Winter DL, Hawkins MM; British Childhood Cancer Survivor Study (BCCSS) Steering Group.

Circulation. 2017 Mar 7;135(10):951-963. doi: 10.1161/CIRCULATIONAHA.116.024811. Epub 2017 Jan 12.

12.

Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.

Henson KE, Reulen RC, Winter DL, Bright CJ, Fidler MM, Frobisher C, Guha J, Wong KF, Kelly J, Edgar AB, McCabe MG, Whelan J, Cutter DJ, Darby SC, Hawkins MM.

Circulation. 2016 Nov 15;134(20):1519-1531. Epub 2016 Nov 7.

13.

Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

Ramroth J, Cutter DJ, Darby SC, Higgins GS, McGale P, Partridge M, Taylor CW.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):736-747. doi: 10.1016/j.ijrobp.2016.07.022. Epub 2016 Jul 25.

14.

Cumulative burden of disease: a relevant measure of the late side-effects of cancer treatment.

Aznar MC, Darby S, Collins GP, Cutter D.

Lancet Oncol. 2016 Sep;17(9):1189-90. doi: 10.1016/S1470-2045(16)30283-2. Epub 2016 Jul 25. No abstract available.

PMID:
27470082
15.

Can Observational Data Replace Randomized Trials?

McGale P, Cutter D, Darby SC, Henson KE, Jagsi R, Taylor CW.

J Clin Oncol. 2016 Sep 20;34(27):3355-7. doi: 10.1200/JCO.2016.68.8879. Epub 2016 Jul 25. No abstract available.

PMID:
27458289
16.

Reply to D. Vordermark and T. Pelz and R. Mazzola et al.

van Nimwegen FA, Cutter DJ, Schaapveld M, Darby SC, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2016 Aug 20;34(24):2941-2. doi: 10.1200/JCO.2016.67.4358. Epub 2016 May 2. No abstract available.

PMID:
27138579
17.

Inferring the Effects of Cancer Treatment: Divergent Results From Early Breast Cancer Trialists' Collaborative Group Meta-Analyses of Randomized Trials and Observational Data From SEER Registries.

Henson KE, Jagsi R, Cutter D, McGale P, Taylor C, Darby SC.

J Clin Oncol. 2016 Mar 10;34(8):803-9. doi: 10.1200/JCO.2015.62.0294. Epub 2016 Jan 19. Retraction in: J Clin Oncol. 2016 Sep 20;34(27):3358-9.

PMID:
26786924
18.

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.

van Nimwegen FA, Schaapveld M, Cutter DJ, Janus CP, Krol AD, Hauptmann M, Kooijman K, Roesink J, van der Maazen R, Darby SC, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2016 Jan 20;34(3):235-43. doi: 10.1200/JCO.2015.63.4444. Epub 2015 Nov 16.

PMID:
26573075
19.

Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.

van Nimwegen FA, Cutter DJ, Schaapveld M, Rutten A, Kooijman K, Krol AD, Janus CP, Darby SC, van Leeuwen FE, Aleman BM.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):153-60. doi: 10.1016/j.ijrobp.2015.02.019.

PMID:
25863762
20.

Risk of valvular heart disease after treatment for Hodgkin lymphoma.

Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, van Nimwegen FA, Krol AD, Janus CP, van Leeuwen FE, Aleman BM.

J Natl Cancer Inst. 2015 Feb 23;107(4). pii: djv008. doi: 10.1093/jnci/djv008. Print 2015 Apr.

21.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.

22.

Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P.

N Engl J Med. 2013 Mar 14;368(11):987-98. doi: 10.1056/NEJMoa1209825.

23.

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K.

Lancet. 2012 Feb 4;379(9814):432-44. doi: 10.1016/S0140-6736(11)61625-5. Epub 2011 Dec 5.

24.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.

Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19. Review.

25.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.

26.

Risks of heart disease after radiotherapy.

Cutter DJ, Darby SC, Yusuf SW.

Tex Heart Inst J. 2011;38(3):257-8. Review. No abstract available.

27.

Radiation-related heart disease: current knowledge and future prospects.

Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ET, Shore RE.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656-65. doi: 10.1016/j.ijrobp.2009.09.064. Review. No abstract available.

28.

Serial isolates of persistent Haemophilus influenzae in patients with chronic obstructive pulmonary disease express diminishing quantities of the HMW1 and HMW2 adhesins.

Cholon DM, Cutter D, Richardson SK, Sethi S, Murphy TF, Look DC, St Geme JW 3rd.

Infect Immun. 2008 Oct;76(10):4463-8. doi: 10.1128/IAI.00499-08. Epub 2008 Aug 4.

29.

Forebrain connectivity of the prefrontal cortex in the marmoset monkey (Callithrix jacchus): an anterograde and retrograde tract-tracing study.

Roberts AC, Tomic DL, Parkinson CH, Roeling TA, Cutter DJ, Robbins TW, Everitt BJ.

J Comp Neurol. 2007 May 1;502(1):86-112.

PMID:
17335041
30.

Myalgias and palpable muscle nodules in a twenty-two year old man.

Cutter D, Rodgers B, Neitzschman H.

J La State Med Soc. 2006 May-Jun;158(3):119-20. No abstract available.

PMID:
16886830
31.

Radiology case of the month. Diagnosing osteomyelitis in a patient with a chronic foot ulcer. Bone marrow hyperplasia secondary to persistent trauma.

Cutter DM, Lee-Valkov P, Rodgers B, Neitzschman HR.

J La State Med Soc. 2006 Mar-Apr;158(2):57-8. No abstract available.

PMID:
16774030
32.

The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate.

Liu DF, Mason KW, Mastri M, Pazirandeh M, Cutter D, Fink DL, St Geme JW 3rd, Zhu D, Green BA.

Infect Immun. 2004 Dec;72(12):6961-8.

33.

The Haemophilus influenzae Hia autotransporter contains an unusually short trimeric translocator domain.

Surana NK, Cutter D, Barenkamp SJ, St Geme JW 3rd.

J Biol Chem. 2004 Apr 9;279(15):14679-85. Epub 2004 Jan 15.

34.

Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas.

O'Neill JM, St Geme JW 3rd, Cutter D, Adderson EE, Anyanwu J, Jacobs RF, Schutze GE.

J Clin Microbiol. 2003 Jul;41(7):3064-9.

35.
36.

Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice.

Cutter D, Mason KW, Howell AP, Fink DL, Green BA, St Geme JW 3rd.

J Infect Dis. 2002 Oct 15;186(8):1115-21. Epub 2002 Sep 16.

PMID:
12355362
38.

Evidence for donor strand complementation in the biogenesis of Haemophilus influenzae haemagglutinating pili.

Krasan GP, Sauer FG, Cutter D, Farley MM, Gilsdorf JR, Hultgren SJ, St Geme JW 3rd.

Mol Microbiol. 2000 Mar;35(6):1335-47.

39.
41.

Characterization of the genetic locus encoding Haemophilus influenzae type b surface fibrils.

St Geme JW 3rd, Cutter D, Barenkamp SJ.

J Bacteriol. 1996 Nov;178(21):6281-7.

42.

Influence of pili, fibrils, and capsule on in vitro adherence by Haemophilus influenzae type b.

St Geme JW 3rd, Cutter D.

Mol Microbiol. 1996 Jul;21(1):21-31.

PMID:
8843431
43.
44.

Health and weight control management among wrestlers. A proposed program for high school athletes.

Perriello VA Jr, Almquist J, Conkwright D Jr, Cutter D, Gregory D, Pitrezzi MJ, Roemmich J, Snyders G.

Va Med Q. 1995 Summer;122(3):179-83, 185.

PMID:
7612683
45.
46.

Cloning and expression of the damselysin gene from Vibrio damsela.

Cutter DL, Kreger AS.

Infect Immun. 1990 Jan;58(1):266-8.

47.

Plasmid DNA of virulent Alcaligenes faecalis.

Luginbuhl GH, Cutter D, Campodonico G, Peace J, Simmons DG.

Am J Vet Res. 1986 Mar;47(3):619-21.

PMID:
3008603

Supplemental Content

Loading ...
Support Center